42C IX Biopharma
- 0.024
- -0.001-4.00%
IX Biopharma News
IX Biopharma Discloses Result of IXB 401 Preclinical Study
IX Biopharma's IXB 401: A Breakthrough in Drug Delivery
IX Biopharma Unveils Growth Plans at AGM
IX Biopharma Ltd. Holds Key Shareholder Meeting
IX Biopharma Restructures Board Committees for Efficiency
IX Biopharma Welcomes Aging Expert to Advisory Board
IX Biopharma Schedules Extraordinary General Meeting for Scheme Extensions
Financial Statements and Related Announcement-Auditor's Comments of Accounts
IX Biopharma Advances Wafermine Out-Licensing, Starts Preclinical Trials for IXB 401
New Study Demonstrates That SL-NAD+ Delivers NAD+ Into Cells
IX Biopharma's New Wafer Revolutionizes NAD+ Supplementation
IX Biopharma Widens Net Loss by 12% in FY2024
IX Biopharma's Net Attributable Loss Widens in Fiscal H2
IX Biopharma Full Year 2024 Earnings: S$0.014 Loss per Share (Vs S$0.013 Loss in FY 2023)
Financial Statements and Related Announcement-Full Yearly Results
IX Biopharma's CBD Wafer Shows Potential in Improving Symptoms for Kidney Failure Patients; Shares Up 4%
IX Biopharma's CBD Wafer Shows Promise for Kidney Failure Symptoms
IX Biopharma Issues 115 Million Rights Shares, 57.5 Million Warrants
IX Biopharma Expands Capital With New Shares and Warrants
Singapore Shares Track Global Losses to End Week in Red; GRP Shares Climb 3%
No Data